Supernus Pharmaceuticals, Inc.

SUPN stock score: 44/100

$42.07 · +2.09% · Scored Oct 22, 2026

Technical
47
Fundamental
41
News
52

The reading

Supernus Pharmaceuticals (SUPN) scores 44 out of 100, which reads weak, higher than 47% of Healthcare stocks and 28% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 47, fundamentals 41.

Among the fundamentals, Price Target at 100 and Institutional Ownership at 100 score highest, while Earnings Growth (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 40 and contrarian oscillators 52.

News sentiment is neutral at 52; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 39 to 72, and it is down 9 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward SUPN’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

41

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Institutional Ownership100

    Institutional ownership measures the percentage held by professional investors.

  • Forward P/E96

    Forward P/E ratio uses estimated future earnings to calculate valuation.

Holding it back

  • Earnings Growth (Quarterly)0

    Quarterly earnings growth measures profit increase versus the prior-year quarter.

  • Earnings Growth (Annual)0

    Annual earnings growth tracks year-over-year profit expansion.

  • Earnings Growth (5-Year)0

    5-year earnings growth evaluates long-term profit trajectory and consistency.

40 weighted scorers; 1 had no data today and are left out rather than counted as zero.

Technical · daily

38

Pulling it up

  • SMA 20 Cross Up100

    SMA 20 Cross Up tracks when very short-term averages cross above the 20-period SMA.

  • SMA 586

    Simple Moving Average (5-period) tracks the average price over the last 5 periods.

  • MACD (12)85

    Moving Average Convergence Divergence tracks the relationship between two exponential moving averages.

Holding it back

  • SMA 200 Cross Up4

    SMA 200 Cross Up tracks when faster moving averages cross above the 200-period SMA.

  • Ichimoku Cloud6

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

  • SMA 2007

    Simple Moving Average (200-period) is the most widely followed long-term trend indicator.

61 weighted scorers; 4 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
52

Technical score by timeframe

ChartScoreWeight
Hourly561
Daily383
Weekly412
Monthly542
Quarterly572

Composite score, last 90 days

05010044Jul 25, 2026Oct 22, 2026Jul 25, 2026: 53Jul 26, 2026: 54Jul 27, 2026: 70Jul 28, 2026: 72Jul 29, 2026: 70Jul 30, 2026: 69Jul 31, 2026: 68Aug 2, 2026: 49Aug 3, 2026: 55Aug 5, 2026: 51Aug 6, 2026: 53Aug 7, 2026: 53Aug 8, 2026: 53Aug 9, 2026: 53Aug 10, 2026: 52Aug 11, 2026: 52Aug 12, 2026: 54Aug 13, 2026: 52Aug 14, 2026: 54Aug 15, 2026: 53Aug 16, 2026: 53Aug 17, 2026: 54Aug 18, 2026: 54Aug 19, 2026: 55Aug 20, 2026: 52Aug 22, 2026: 46Aug 23, 2026: 46Aug 24, 2026: 44Aug 25, 2026: 45Aug 26, 2026: 44Aug 27, 2026: 44Aug 28, 2026: 44Aug 29, 2026: 45Aug 30, 2026: 45Aug 31, 2026: 44Sep 1, 2026: 45Sep 2, 2026: 46Sep 3, 2026: 49Sep 4, 2026: 44Sep 5, 2026: 44Sep 6, 2026: 44Sep 7, 2026: 44Sep 8, 2026: 44Sep 9, 2026: 42Sep 10, 2026: 42Sep 11, 2026: 43Sep 12, 2026: 43Sep 13, 2026: 43Sep 14, 2026: 43Sep 15, 2026: 42Sep 16, 2026: 43Sep 17, 2026: 45Sep 18, 2026: 43Sep 19, 2026: 43Sep 20, 2026: 43Sep 21, 2026: 44Sep 22, 2026: 46Sep 23, 2026: 47Sep 24, 2026: 46Sep 25, 2026: 44Sep 26, 2026: 44Sep 27, 2026: 44Sep 28, 2026: 46Sep 29, 2026: 47Sep 30, 2026: 45Oct 1, 2026: 43Oct 2, 2026: 43Oct 3, 2026: 43Oct 4, 2026: 43Oct 5, 2026: 45Oct 6, 2026: 45Oct 7, 2026: 45Oct 8, 2026: 43Oct 9, 2026: 45Oct 10, 2026: 45Oct 11, 2026: 45Oct 12, 2026: 45Oct 13, 2026: 43Oct 14, 2026: 42Oct 15, 2026: 41Oct 16, 2026: 39Oct 17, 2026: 40Oct 18, 2026: 40Oct 19, 2026: 42Oct 20, 2026: 44Oct 21, 2026: 44Oct 22, 2026: 44
Show the daily numbers
DateComposite
Oct 22, 202644
Oct 21, 202644
Oct 20, 202644
Oct 19, 202642
Oct 18, 202640
Oct 17, 202640
Oct 16, 202639
Oct 15, 202641
Oct 14, 202642
Oct 13, 202643
Oct 12, 202645
Oct 11, 202645
Oct 10, 202645
Oct 9, 202645
Oct 8, 202643
Oct 7, 202645
Oct 6, 202645
Oct 5, 202645
Oct 4, 202643
Oct 3, 202643
Oct 2, 202643
Oct 1, 202643
Sep 30, 202645
Sep 29, 202647
Sep 28, 202646
Sep 27, 202644
Sep 26, 202644
Sep 25, 202644
Sep 24, 202646
Sep 23, 202647
Sep 22, 202646
Sep 21, 202644
Sep 20, 202643
Sep 19, 202643
Sep 18, 202643
Sep 17, 202645
Sep 16, 202643
Sep 15, 202642
Sep 14, 202643
Sep 13, 202643
Sep 12, 202643
Sep 11, 202643
Sep 10, 202642
Sep 9, 202642
Sep 8, 202644
Sep 7, 202644
Sep 6, 202644
Sep 5, 202644
Sep 4, 202644
Sep 3, 202649
Sep 2, 202646
Sep 1, 202645
Aug 31, 202644
Aug 30, 202645
Aug 29, 202645
Aug 28, 202644
Aug 27, 202644
Aug 26, 202644
Aug 25, 202645
Aug 24, 202644
Aug 23, 202646
Aug 22, 202646
Aug 20, 202652
Aug 19, 202655
Aug 18, 202654
Aug 17, 202654
Aug 16, 202653
Aug 15, 202653
Aug 14, 202654
Aug 13, 202652
Aug 12, 202654
Aug 11, 202652
Aug 10, 202652
Aug 9, 202653
Aug 8, 202653
Aug 7, 202653
Aug 6, 202653
Aug 5, 202651
Aug 3, 202655
Aug 2, 202649
Jul 31, 202668
Jul 30, 202669
Jul 29, 202670
Jul 28, 202672
Jul 27, 202670
Jul 26, 202654
Jul 25, 202653

Key facts

Market cap
$2.4B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
0.55
Risk grade (1–10)
5
Next earnings
Oct 29, 2026

Drug Manufacturers - Specialty & Generic peers

CompanyMarket capScore
AMLX Amylyx Pharmaceuticals$3.6B54
LQDA Liquidia$3.6B56
HCM HUTCHMED (China)$2.5B55
BHC Bausch Health Companies$2.4B57
PBH Prestige Consumer Healthcare$2.3B49
PRGO Perrigo Company$2.3B43

Questions

What is SUPN's stock score today?

SUPN scores 44/100 (Weak) as of Oct 22, 2026: technical 47, fundamental 41, and news sentiment 52, which is shown but not counted. Scores are recomputed every night.

Is SUPN a buy?

The score is not a buy or sell recommendation. A 44 says the technical and fundamental signals we measure lean weak today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the SUPN score calculated?

101 weighted scorers feed it today: 40 fundamental, scored against Healthcare ranges, and 61 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.